| TTM
|
8/31/2024
|
8/31/2023
|
8/31/2022
|
|
|---|---|---|---|---|
| Total Revenue
|
104.8100 | 96.1800 | 72.0960 | 165.5960 |
| Cost of Revenue
|
-431.3670 | -419.3120 | -1,533.8630 | -91.4760 |
|
Gross Profit
|
-326.5570 | -323.1320 | -1,461.7670 | 74.1200 |
| Selling, General and Administrative Expenses
|
-1,655.4560 | -1,871.0910 | -4,655.6020 | -13,111.7750 |
|
Research and Development Expenses
|
0 | -- | 0 | -12.0620 |
| Depreciation, Amortization and Depletion
|
-137.6930 | -139.7690 | -137.0460 | -82.5890 |
| Other Income/Expense, Operating
|
-560.5570 | -505.0480 | -576.5930 | -1,177.2300 |
|
Operating Income/Expenses
|
-2,353.7060 | -2,515.9080 | -5,369.2410 | -14,383.6560 |
|
Total Operating Profit/Loss
|
-2,680.2630 | -2,839.0400 | -6,831.0080 | -14,309.5360 |
| Total Net Finance Income/Expense
|
-855.0100 | -848.8660 | -863.2030 | -1,234.3560 |
| Net Investment Income
|
-384.5280 | -288.2780 | -147.7220 | 1.3930 |
| Irregular Income/Expenses
|
0 | 0 | -2,833.7380 | 3.6460 |
|
Other Income/Expense, Non-Operating
|
-- | -- | -- | 0 |
|
Non-Operating Income/Expenses, Total
|
-1,239.5380 | -1,137.1440 | -3,844.6630 | -1,229.3170 |
|
Pretax Income
|
-3,919.8010 | -3,976.1840 | -10,675.6710 | -15,538.8530 |
|
Net Income from Continuing Operations
|
-3,919.8010 | -3,976.1840 | -10,675.6710 | -15,538.8530 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-3,919.8010 | -3,976.1840 | -10,675.6710 | -15,538.8530 |
|
Net Income after Non-Controlling/Minority Interests
|
-3,919.8010 | -3,976.1840 | -10,675.6710 | -15,538.8530 |
|
Net Income Available to Common Stockholders
|
-3,919.8010 | -3,976.1840 | -10,675.6710 | -15,538.8530 |
|
Diluted Net Income Available to Common Stockholders
|
-3,919.8010 | -3,976.1840 | -10,675.6710 | -15,538.8530 |
| Basic EPS
|
-0.05 | -0.04 | -0.11 | -0.17 |
| Diluted EPS
|
-0.05 | -0.04 | -0.11 | -0.17 |
|
Basic Weighted Average Shares Outstanding
|
108,284.8510 | 105,640.7000 | 96,797.7140 | 92,098.0500 |
|
Diluted Weighted Average Shares Outstanding
|
108,284.8510 | 105,640.7000 | 96,797.7140 | 92,098.0500 |
| Income Statement, Supplemental
|
||||
|
EBIT
|
-3,064.7910 | -3,127.3180 | -9,812.4680 | -14,304.4970 |
|
EBITDA
|
-2,927.0980 | -2,987.5490 | -9,675.4220 | -14,221.9080 |
|
Normalized EBITDA
|
-2,516.1830 | -2,486.9220 | -2,083.0580 | -6,870.8720 |
|
Normalized Income
|
-3,508.8860 | -3,475.5570 | -3,083.3070 | -8,187.8170 |
|
Total Unusual Items
|
410.9150 | 500.6270 | 7,592.3640 | 7,351.0360 |
8/31/2022 - 8/15/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade